OR WAIT null SECS
December 08, 2017
The new 30,000-L, $150-million biologics manufacturing facility in Wuxi, China, quintuples the company’s existing manufacturing capability.
December 06, 2017
The contract research, development, and manufacturing organization has expanded API aseptic manufacturing capacity at its Valladolid, Spain, facility.
The company will expand two of its Ohio facilities, investing approximately $145 million to support manufacturing and warehouse operations.
December 02, 2017
Optimizing water and HVAC systems can reduce resource use in all pharma facilities, and, for biopharma manufacturing, the supply chain of consumables should be evaluated.
December 01, 2017
The company has opened a new California facility that, combined with its existing site in Foster City, CA, will quadruple its laboratory footprint for gene therapy products.
November 15, 2017
A new facility type integrates next-generation mobile cleanroom systems.
The use of approved platform technologies can reduce the time and cost required to generate new vaccines.
November 13, 2017
The company has completed a small-scale capacity expansion at its site in Charles City, IA.
Company completes first successful run of what is believed to be the largest synthesis-scale done for oligonucleotide APIs.